Balanced news tone
News Sentiment
AVR sentiment intelligence
Anteris Technologies Global Corp. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
91/100 classification confidence.
directly relevant articles
high-authority source matches
-9.7% over one week, +1.7% over four weeks, trend active, and near fair-value range.
Anteris Technologies (AVR) Drops 6.15% as Stock Tests Key Support at $9.42 - Trend Reversal Picks
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Anteris Technologies (AVR) Drops 6.15% as Stock Tests Key Support at $9.42 - Trend Reversal Picks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 01:33
- Source
- dars.gov.et
Anteris Technologies Files Offering of Up to 5.39 Million Shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- Moomoo
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell 2000 Growth Benchmark
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 29 Jun 2026 11:36
- Source
- marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell 3000 Value Benchmark
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 07:00
- Source
- marketscreener.com
Enterprise value to revenue forward of Anteris Technologies Global Corp. – NASDAQ:AVR
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Jun 2026 01:48
- Source
- TradingView
Anteris Technologies Global Corp (AVR) Valuation: PE, PB & Fair Value Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 02:55
- Source
- TradingKey
Severe aortic stenosis patients in France can join Anteris heart valve trial
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 07:00
- Source
- Stock Titan
Anteris Technologies Global Launches $250 Million ATM Offering Under Sales Agreement With TD Cowen
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- TradingView
We Think Anteris Technologies Global (ASX:AVR) Can Afford To Drive Business Growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
First U.S. patients enter Anteris heart valve trial for stenosis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- Stock Titan
Anteris Technologies ends development agreement with v2vmedtech, pays $400,000 fee
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Apr 2026 07:00
- Source
- Investing.com
Anteris Technologies Looks Bullish If DurAVR's PARADIGM Delivers
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- Seeking Alpha
Anteris Technologies price target lowered to $15 from $20 at Lake Street
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 24 Jan 2026 08:00
- Source
- Market source
Retail investors who hold 25% of Anteris Technologies Global Corp. (ASX:AVR) gained 41%, institutions profited as well
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jan 2026 08:00
- Source
- Market source
Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jan 2026 08:00
- Source
- Market source